This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
11 Lessons We Learned About Protecting Assets and Risks in M&A by Interviewing Joe Prencipe. Ron Concept 1: Know The Risks of M&A When it comes to mergers and acquisitions (M&A), it is essential to understand the risks involved. -Ron M&A can be a great way to expand a business, but it can also be very risky.
Navigating M&A valuations with precision is paramount for informed decision-making. Our guide equips you with step-by-step instructions on employing the Enterprise Value Calculator effectively, complete with insights into optimal practices for precision valuations.
With a background in finance and accounting from his time at Deloitte, Ryan has built his expertise in business valuation. He is the founder of Peak Business Valuation, a firm dedicated to providing independent third-party valuation services for SBA lenders and individuals. They just learned the game of business."
On the latest episode of The Deal’s Behind the Buyouts podcast, Solomon Partners co-head of consumer and retail Cathy Leonhardt talks about the sector’s slow start to M&A this year, categories that continue to shine and potential signs of a resurgence in dealmaking. portfolio company Birkenstock GmbH & Co. .”
Business photo created by rawpixel.com – www.freepik.com CHICAGO, IL – February 23, 2024 – A distinguished specialty plastics provider for medical devices out of Northern California, has initiated a sell-side engagement represented by Sun Acquisitions.
Valuation and a company's balance sheet lie at opposite ends of the financial spectrum. While a balance sheet provides a snapshot of a company's financial position on a specific date, valuation reflects expectations of the company's worth several years into the future.
January 9, 2024 2023: A Year of Strategic Consolidation and Diversification In 2023, the Healthcare IT sector witnessed a significant transformation marked by strategic mergers and acquisitions (M&A).
The 6th annual Midwest M&A/Private Equity Forum sponsored by the Thomson Reuters Institute was held in early December in Columbus, Ohio, and for your humble correspondent, this was not only my second time as one of the participants, but my first time as a moderator of a panel! More on that later.
In this post, we’ll offer further insights into what’s driving the need for healthcare SaaS solutions and how business owners can capitalize on heightened activity in healthcare M&A. Few would disagree the American healthcare sector faces a great many challenges in terms of accessibility, affordability, and quality of care.
In this post, we’ll offer further insights into what’s driving the need for healthcare SaaS solutions and how business owners can capitalize on heightened activity in healthcare M&A. Few would disagree the American healthcare sector faces a great many challenges in terms of accessibility, affordability, and quality of care.
M&A Beat – US Health Services Q2 2020 M&A Beat is a quarterly update for CEO’s, CFO’s, Owner, Founders of lower middle-market ($10M-$100M Rev) companies, offering relevant details on mergers and acquisitions deal value, volume, valuation multiples and trends in their respective industry and vertical. acquisition.
In a roll-up strategy, a private equity firm will attempt to consolidate a large number of smaller firms into a single, professionalized company with numerous benefits, including economies of scale and fixed cost leverage, valuation uplift (so-called “multiple arbitrage”), and acquisition expertise, among others.
What’s on tap for 2018 M&A? As an example, for California specific requirements, see our prior blog post Non-Competes for California Employees in M&A Deals: Don’t Fudge It. A recap of 2017 trends and the Cooley outlook on this year’s dealmaking: Buying Innovation: Retention and Non-Competes.
2019 was a banner year for billion-dollar life sciences M&A transactions. A wave of big-ticket transactions by global pharmaceutical companies drove life sciences M&A activity to its fourth-largest year on record in 2019, with aggregate deal value in the pharmaceutical, medical and biotech industry reaching $234.2
In a subdued year for global M&A, deal-making in the life sciences industry came in waves, with a busy fourth quarter generating cautious optimism heading into 2024. Big pharma dominated life sciences M&A, with more than two-thirds (69%) of M&A investment coming from big pharma, compared to just 38% in 2022.
Although 2022 saw a general decline in M&A activity in the life sciences industry compared to 2021’s frenetic pace (when deal volume was up 52% from 2020 ), life sciences deal flow in 2022 on balance remained strong despite the headwinds. Let’s dig in.
The geriatric population and the increasing incidence of acute diseases, including bladder cancer and other diseases associated with the bladder, are the main reasons for this growth.
continues their goal of acquiring and integrating leading medical aesthetics clinics, enabling medical professionals in their subsidiaries to achieve personal and professional goals while creating world-class customer experiences by networking support, collaboration, and community. About MedSpa Partners Inc.
Their team is experienced in M&A, and they hire the best talent available. rn Kurt emphasizes that AI can be a powerful tool in the M&A process, particularly in gathering and analyzing large amounts of data. Reconciled sets the standard for consistency and quality that you can count on. rn rn Quotes: rn rn "AI isn't scary.
These products are used for food packaging and processing, medical, printing, automotive, material handling systems and other applications. We work with clients that are interested in the confidential sale , acquisition or valuation of privately held companies. Custom Cylinders, Inc.
Specializing in precision metal services and medical manufacturing, Grace has earned a stellar reputation for delivering custom metal parts utilizing various cutting-edge processes. to Grace Manufacturing appeared first on Sun Acquisitions | Chicago Business Broker and M&A Firm. CHICAGO, IL, April 2, 2024 — Griffin Products, LLC.,
Return Logistics International was established in 1996, and currently provides manufacturer returns processing, as well as product and waste destruction and disposal for manufacturers, wholesalers, retail and institutional pharmacies, medical practitioners and dispensers, animal hospitals, animal clinics, and veterinarians.
Buying an existing business can be a smart move, offering the benefits of an established operation. However, it also comes with its own set of challenges, especially regarding legal and financial complexities. Conducting thorough due diligence is crucial to uncover hidden issues, such as undisclosed debts or potential legal disputes.
Main Capital has made 215 total investments since its founding, with current assets under management (AUM) of $2.37B and an active portfolio of 47 firms, with a median valuation of $10.25M. Thoma Bravo maintains an active portfolio of 76 firms, with $134B in AUM and a $435M median valuation. The firm employs 93 professionals.
The proliferation of Vocational Technology (VocTech) solutions has also played a pivotal role, offering innovative and accessible avenues for workforce development. As we project toward 2025, this sector is poised to sustain its robust performance, driven by substantial investor interest and the opportunities presented by a highly fragmented market.
The short answer to #1 is that healthcare private equity firms operate in specific verticals with stable-ish cash flows, such as healthcare services, nursing facilities, medical devices, equipment, and healthcare IT. Why do PE firms operate there? Don’t they need companies with stable cash flows? For example, in the U.S.,
company to hit a $1 trillion valuation , it directly benefited shareholders. The distinction between them is crucial for understanding a company's obligations, its strategy, and the interplay of interests within its ecosystem. What is a Shareholder? A shareholder is an individual or entity that owns shares or stock in a corporation.
No one really knows how the pandemic will play out from a medical, economic, political, and societal perspective. No one really knows how the pandemic will play out from a medical, economic, political, and societal perspective. The question is, “Why?”. After all, our world has changed substantially. We face a future of uncertainty.
He tried a medical website, local portals, computer networking, and websites. Ron Concept 1: Set Your Own Agenda Scotty's story also highlights the importance of setting your own agenda. In business, you have to make your own season and create your own agenda. It's also important to remember that you don't have to do it alone.
In life sciences/medical technology transactions, buyers and sellers often use milestone-based and sometimes royalty-based contingent consideration to compensate sellers for assets that are in various stages of development from clinical- to development-stage to product commercialization. [1] Private placement.
If you’re considering buying or selling a business, you’ve likely come across the term “business broker.” ” A business broker facilitates transactions as a middleman between sellers and buyers. Whether the goal is to sell or buy, understanding what a business broker does is crucial for a smooth, efficient process.
General trends in life sciences M&A. While 2020’s M&A landscape was characterized by whiplash volatility from choppy deal activity in the first half of the year to a surge in volume in the second half, that momentum accelerated in 2021, with no signs of slowing down heading into 2022. driven assets.
Cross-border M&A activity in 2023 was impacted by heightened geopolitical conflicts, high inflation and interest rates, and increased regulatory pressures as the global economy remained clouded by looming recession fears. The aggressive rate hikes contributed to the decline in M&A activity in 2023. trillion and $4.09
President Biden has also proposed applying ordinary income tax rates to the capital gains and qualified dividends of taxpayers with taxable income of more than $1.0 The tax for the initial year would be paid over nine years, and over five years for subsequent years.
Tech M&A in 2022 was a tale of two halves. 2] Despite the downtrend, global tech M&A activity in 2022 remained strong relative to pre-pandemic levels and accounted for a record 20% of all global M&A activity. Deal volumes dropped from $531.13 billion [1] during the first half of 2022 to $189.17 trillion. [2]
Business brokers and M&A advisors are often used interchangeably, but their roles and expertise differ significantly. Understanding the Difference Between a Business Broker and an M&A Advisor Both business brokers and M&A advisors facilitate business transactions, but their focus, client base, and approach set them apart.
Unlike in 2023, when a Q4 dealmaking binge over the holidays led to the sector outperforming the market, life sciences M&A cut down and stuck with it throughout 2024. Unlike in 2023, when a Q4 dealmaking binge over the holidays led to the sector outperforming the market, life sciences M&A cut down and stuck with it throughout 2024.
Chicago, IL January 31, 2025 Sun Acquisitions, a leading mergers and acquisitions firm, is pleased to announce the successful sale of Home Care Angels, an independently owned and operated non-medical home service agency to Avid Health at Home Illinois, LLC, a personalized in-home care organization that provides support to individuals of all ages.
In 2012, 25% of senior citizens had to declare bankruptcy due to medical expenses or were forced to mortgage their residences. The healthcare industry is formed of numerous subsectors including pharmaceutical services, diagnostics, medical technologies, and managed healthcare. What is the healthcare industry and its major subsectors?
We organize all of the trending information in your field so you don't have to. Join 38,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content